HannoRHockMD

Assistant Professor of Medicine, Massachusetts General Hospital

Dr. Hock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
55 Fruit St
# Hematolo
Boston, MA 02114
Phone+1 617-724-4000

Fax+1 617-726-2894

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1993 - 1996
Freie University Berlin Faculty of MedicineClass of 1989

PubMed

4 citations
Ixazomib in addition to chemotherapy for the treatment of acute lymphoblastic leukemia in older adults.
Philip Amrein, Karen Ballen, Kristen Stevenson, Andrew Brunner, Gabriela Hobbs
Leukemia & Lymphoma. 2022-06-01
A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies.
Joan How, Siyang Ren, Jennifer Lombardi-Story, Meghan Bergeron, Julia Foster
Ejhaem. 2022-05-01
3 citations
Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy.
Valentina Nardi, Steven L McAfee, Paola Dal Cin, Harrison K Tsai, Philip C Amrein
The Oncologist. 2022-03-04

Lectures

Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Mye...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

MGH Study Identifies First Molecular Steps to Childhood LeukemiaJuly 15th, 2009
Some Blood-System Stem Cells Reproduce More Slowly Than ExpectedDecember 5th, 2008